HETEROBICYCLIC SULFONAMIDES AND THEIR USE AS PLATELET ADP RECEPTOR INHIBITORS

(19)

(11)

EP 1 278 744 A1

(12)

(43)	Date of publication:
	29.01.2003 Bulletin 2003/05

(21)	Application number: 01938998.0

(22)	Date of filing: 04.05.2001

(51)

International Patent Classification (IPC)⁷: C07D 409/14, C07D 409/12, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14, C07D 495/04, C07D 498/04, C07D 513/04, A61K 31/4184, A61K 31/423, A61K 31/428, A61K 31/4745, A61K 31/517, A61P 7/02
// (C07D495/04, 333:00), C07D221:00,(C07D498/04, 263:00), C07D221:00,(C07D513/04, 277:00), C07D221:00

(86)	International application number:
	PCT/US0114/441

(87)	International publication number:
	WO 0108/5722 (15.11.2001 Gazette 2001/46)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

05.05.2000 US 202075 P
06.09.2000 US 230456 P

(71)	Applicant: MILLENIUM PHARMACEUTICALS, INC.
	Cambridge, MA 02139 (US)

(72)	Inventors:
	SCARBOROUGH, Robert, M. Half Moon Bay, CA 94019 (US) MARLOWE, Charles, K. Redwood City, CA 94080 (US)

(74)	Representative: Thomson, Paul Anthony
	Potts, Kerr & Co.,15, Hamilton Square Birkenhead,Merseyside CH41 6BR Birkenhead,Merseyside CH41 6BR (GB)

(54)	HETEROBICYCLIC SULFONAMIDES AND THEIR USE AS PLATELET ADP RECEPTOR INHIBITORS